Richard Rosenquist

发表

IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.

K. Stamatopoulos, Š. Pospíšilová, L. Mansouri, 2024, Leukemia.

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.

T. Fioretos, P. Baliakas, V. Wirta, 2024, Genes, chromosomes & cancer.

Drug-perturbation-based stratification of blood cancer

Andrzej K. Oleś, C. von Kalle, W. Huber, 2017, The Journal of clinical investigation.

Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities

K. Stamatopoulos, T. Chatzikonstantinou, S. Pavlova, 2024, HemaSphere.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update

K. Stamatopoulos, T. Chatzikonstantinou, S. Stilgenbauer, 2024, Leukemia.

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

K. Stamatopoulos, T. Shanafelt, Š. Pospíšilová, 2024, Leukemia.

Time to include IGLV3-21R110 status in CLL prognostication?

Richard Rosenquist, Richard Rosenquist, 2023, Blood advances.

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond

E. Hovig, H. Russnes, J. Lehtiö, 2024, Journal of internal medicine.

Smart variant filtering - A blueprint solution for massively parallel sequencing-based variant analysis

K. Smedby, V. Wirta, F. Taylan, 2024, Health Informatics J..